HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery.

Abstract
Seven consecutive female patients with pathologically confirmed arteriovenous malformation (AVM) with intravenous leiomyomatosis (IVL) of the uterus (age range, 32-61 years; mean age, 43 years) treated between 2005 and 2021 from a single institution were reviewed. Computed tomography (CT) findings of congenital pelvic AVM of 10 female patients were compared with those of AVM with IVL. Characteristic CT findings of AVM with IVL revealed a focal soft tissue mass inside a dilated venous structure of the AVM. Multiple sessions of transvenous coil embolization of the AVM with or without the injection of ethanol were performed. After complete (6/7, 86%) or partial (1/7, 14%) embolization of the AVM, complete surgical resection of the IVL and embolized AVM mass was performed in 4 patients. Patients with lung metastasis or residual embolized AVM masses are under follow-up with antiestrogen hormonal therapy.
AuthorsJun Gon Kim, Yang-Jin Park, Young Soo Do, Byoung-Gie Kim, Jeong-Won Lee, Chel Hun Choi, Hyeong Chun Kim, Kwang Bo Park, Dong-Ho Hyun
JournalJournal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 34 Issue 1 Pg. 103-107 (01 2023) ISSN: 1535-7732 [Electronic] United States
PMID36241150 (Publication Type: Journal Article)
CopyrightCopyright © 2022 SIR. Published by Elsevier Inc. All rights reserved.
Topics
  • Humans
  • Female
  • Adult
  • Middle Aged
  • Leiomyomatosis (diagnostic imaging, surgery)
  • Arteriovenous Malformations (diagnostic imaging, therapy)
  • Embolization, Therapeutic (methods)
  • Tomography, X-Ray Computed
  • Uterus
  • Intracranial Arteriovenous Malformations (surgery)
  • Treatment Outcome
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: